We are live on
!
Find out more
CM
Capital Management Portfolio holdings
AUM
$585M
1-Year Est. Return
5.18%
This Fund
S&P 500
This Quarter
Est. Return
+3.01%
1 Year Est. Return
+5.18%
3 Year Est. Return
+40.88%
5 Year Est. Return
+39.5%
10 Year Est. Return
+202.53%
AUM
$335M
AUM Growth
+$12.3M
(+3.8%)
Cap. Flow
+$6.11M
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
99
New
8
Increased
33
Reduced
38
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omega Healthcare
OHI
|
+$7.14M |
| 2 |
WisdomTree Europe SmallCap Dividend Fund
DFE
|
+$5.16M |
| 3 |
Aon
AON
|
+$3.06M |
| 4 |
Walt Disney
DIS
|
+$3M |
| 5 |
ORBK
Orbotech Ltd
ORBK
|
+$2.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$4.01M |
| 2 |
Anika Therapeutics
ANIK
|
+$3.89M |
| 3 |
Las Vegas Sands
LVS
|
+$3.66M |
| 4 |
United Therapeutics
UTHR
|
+$3.42M |
| 5 |
Marriott International
MAR
|
+$3.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.62% |
| 2 | Consumer Discretionary | 19.48% |
| 3 | Healthcare | 10.84% |
| 4 | Industrials | 9.88% |
| 5 | Real Estate | 7.89% |
Similar funds
RIS
TAM
CGIM
HA
GIM
KI
PFG
AIM
Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Capital Management held 99 positions worth $335M, up 3.8% from $323M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Capital Management's Q2 2017 filing shows 8 new, 33 increased, 38 reduced and 4 closed positions. Its largest new stake was Omega Healthcare: 215,820 shares worth $7.13M. The largest sale was Applied Materials, an estimated $4.01M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Capital Management's largest Q2 2017 buy was Omega Healthcare: 215,820 shares worth $7.13M.
- Capital Management added most to Aon in Q2 2017, an estimated $3.06M increase.
- Capital Management's biggest Q2 2017 reduction was Applied Materials, cutting an estimated $4.01M.
- Capital Management fully exited United Therapeutics in Q2 2017, selling an estimated $3.42M.
- Capital Management's ten largest holdings make up 32% of its $335M portfolio in Q2 2017.
- Capital Management opened 8 new positions and closed 4 in Q2 2017.
- Capital Management's portfolio value rose 3.8% quarter-over-quarter to $335M.
Based on Capital Management's 13F filing for Q2 2017, filed 17 Jul 2017.